Eric Marler
Internal Medicine · Seneca, SCNPI 1598798910
Payments from drug & device makers
Across 206 payments — averaging $16.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$811
- Lilly USA, LLC$542
- AstraZeneca$476
- GSK$220
- AbbVie$189
- Pfizer$125
- plus $943 from 24 others
What the payments were for
- Food & beverage$3,300100%
- Education$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 56 | $811 |
| Lilly USA, LLC | 36 | $542 |
| AstraZeneca | 25 | $476 |
| GSK | 15 | $220 |
| AbbVie | 10 | $189 |
| Pfizer | 8 | $125 |
| Bayer | 6 | $95 |
| Dexcom, Inc. | 5 | $83 |
| Amgen | 5 | $78 |
| Phathom Pharmaceuticals, Inc. | 5 | $70 |
| Abbott | 4 | $63 |
| Merck | 3 | $58 |
| Exact Sciences | 4 | $58 |
| Idorsia Pharmaceuticals US Inc | 1 | $58 |
| Neurocrine Biosciences, Inc. | 2 | $38 |
| Astellas Pharma US Inc | 2 | $36 |
| Novartis | 2 | $33 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $32 |
| Nestle Healthcare Nutrition Inc. | 2 | $31 |
| Xeris Pharmaceuticals, Inc. | 2 | $31 |
| Johnson & Johnson | 2 | $25 |
| Eisai Inc. | 1 | $24 |
| Lundbeck LLC | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| Biosense Webster, Inc. | 1 | $19 |
| Amarin Pharma, Inc. | 1 | $15 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| Boehringer Ingelheim | 1 | $15 |
| Daiichi Sankyo Inc. | 1 | $14 |
| Boston Scientific | 1 | $11 |
How this compares
$3,306 in reported general payments places this provider in the 80th percentile of 1,498 internal medicine providers in South Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 243 | $319,647 |
| EliquisApixaban | 129 | $130,926 |
| JardianceEmpagliflozin | 75 | $115,075 |
| MounjaroTirzepatide | 75 | $98,400 |
| FarxigaDapagliflozin Propanediol | 62 | $63,066 |
| XareltoRivaroxaban | 32 | $42,464 |
| Tresiba Flextouch U-200Insulin Degludec | 15 | $26,896 |
| TrulicityDulaglutide | 19 | $21,295 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 15 | $19,705 |
| JanumetSitagliptin Phos/Metformin Hcl | 25 | $16,380 |
| MyrbetriqMirabegron | 21 | $14,118 |
| Tresiba Flextouch U-100Insulin Degludec | 16 | $13,752 |
| Fiasp FlextouchInsulin Aspart (Niacinamide) | 15 | $10,997 |
| Breo ElliptaFluticasone/Vilanterol | 16 | $8,609 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 29 | $8,313 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $811 | $319,647243 claims |
| PfizerEliquis, Premarin | $125 | $133,428143 claims |
| Lilly USA, LLCMounjaro, Trulicity | $542 | $119,69494 claims |
| Boehringer IngelheimJardiance | $15 | $115,07575 claims |
| AstraZenecaFarxiga | $476 | $63,06662 claims |
| Johnson & JohnsonXarelto | $25 | $42,46432 claims |
| MerckJanumet | $58 | $16,38025 claims |
| Astellas Pharma US IncMyrbetriq | $36 | $14,11821 claims |
| GSKBreo Ellipta | $220 | $8,60916 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,498 internal medicine providers in South Carolina.
Other internal medicine in Seneca
- Rica SantiagoMt Pleasant$10.7M
- Richard MillsMt Pleasant$5.5M
- Yvonne DavisMount Pleasant$2.4M
- David BolsterSummerville$2.3M
- Colby GrossmanSummerville$1.4M
- Amit ShahIndian Land$1.4M
- Philip NicolMurrells Inlet$782K
- Carl SofleyAnderson$673K
- Carl MitchellColumbia$564K
- Jerry BackNorth Charleston$322K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.